gp48 D29 protein (by RasWin software)
![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgRvdjrHG-ZNTF4XDpoGdHBqoZNHV9sGsujpw6iPDLeuXxJsG5D6Wlo6WxUnN0bQ4s0OlyQeoPezRnO86Kq4BAGP2lSZVscdS827sCudVCHgsx1fHc3CeHjJoWBkTe1MZ0w7s8K2pzPo-s/s400/gp48+D29+protein+from++thyX+protein+of+M.tuberculosis.jpg)
If the target host* of a phage therapy treatment is not an animal the term "biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".
"In silico"
From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson
Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.